Head-to-head · computed 2026-08-11
Amble Health vs Willow
Amble Health: A no-membership program with $300/month flat tirzepatide. Willow: Willow sells patient-specific 503A compounded tirzepatide at a flat $399 a month at every dose, telehealth and shipping included, in 33 states as of mid-2026 reporting.
Tirzepatide
| Amble Health | Willow | |
|---|---|---|
| All-in maintenance | $300/mo | $399/mo |
| Best plan rate | $300/mo | $399/mo |
| 12-month total | $3,600 | $4,788 |
| Status | Provider-stated · 2026-08-05 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, Amble Health's $300 a month undercuts Willow's $399 by $99 a month at the 10 mg/wk maintenance basis — $1,188 across a year. Amble Health's figure is provider-stated (captured 2026-08-05) and Willow's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Amble Health's tirzepatide ladder runs $300 a month billed monthly. Willow's runs $399 a month billed monthly. On the twelve-month basis Amble Health's $3,600 beats Willow's $4,788 by $1,188 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Where the structures genuinely differ
On verifiability, Amble Health names its dispensing pharmacy — which means the fifteen-minute license-and-records check is possible — while Willow's pharmacy is not disclosed on record, the single structural fact this desk weighs heaviest after the FDA's 2026 letters cited exactly that practice.
Structure, side by side
Amble Health
- MembershipNone
- Dose policyDose-flat
- CommitmentMonth-to-month
- CancellationCancel before renewal
- PharmacyPartner pharmacies
Willow
- MembershipNone
- Dose policyDose-flat per captured reporting: flat $399 at every dose
- CommitmentMonthly
- CancellationPer published terms; confirm at checkout
- PharmacyPatient-specific 503A compounding (pharmacy unnamed on captured materials)
What our desk is watching on each
Amble Health: Provider-stated; checkout capture pending.
Willow: Reported from a June 15, 2026 comparison table (MenoMellow) — our own capture pending; the flat-at-every-dose structure and 33-state footprint both carry that single-source status until independently confirmed. Pharmacy unnamed on captured materials.
Questions people ask
Is Amble Health or Willow cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Amble Health vs Willow miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Amble Health and Willow cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $3,600 at Amble Health and $4,788 at Willow — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Amble Health · Willow. Official sites: Amble Health ↗ · Willow ↗. Nothing here is medical advice.